CdSe/ZnS Quantum Dots: Handling, Dilution & Imaging Protocol

CdSe/ZnS Quantum Dots is a core–shell colloidal nanocrystal combining a cadmium selenide emitting core with a zinc sulfide passivating shell, delivering narrow-bandwidth, size-tunable fluorescence ideal for bioimaging, biosensing, and single-particle tracking applications.

Core/Shell Composition

CdSe core with ZnS passivating shell

Emission Tunability

Emission wavelength tunable across visible to near-infrared spectrum depending on core size

Fluorescence Quantum Yield

Typically high quantum yield due to ZnS shell passivation (consult product CoA for lot-specific value)

Recommended Storage

Store at 2–8 °C in the dark; avoid repeated freeze–thaw cycles

Solvent Compatibility

Typically dispersed in organic solvents (e.g., toluene, hexane) or aqueous buffers if surface-functionalised

SKU

C139731

Materials and Safety Precautions

Before beginning, gather the following materials: CdSe/ZnS Quantum Dots (SKU C139731), appropriate organic solvent or aqueous buffer (depending on surface ligand), UV lamp or fluorescence spectrophotometer for emission verification, microcentrifuge tubes (amber or foil-wrapped), nitrile gloves, lab coat, and safety goggles.

Safety: CdSe/ZnS quantum dots contain cadmium, a toxic heavy metal, and selenium compounds. Handle strictly in accordance with your institution's chemical safety guidelines. Wear appropriate personal protective equipment (PPE) at all times. Dispose of all waste, including used tips, tubes, and solvent washes, as hazardous heavy-metal waste in compliance with local regulations. Refer to the Safety Data Sheet (SDS) for C139731 prior to use. Avoid inhalation of aerosols or dust. Work in a well-ventilated area or fume hood when using organic solvents.

Stock Solution Preparation and Dilution

Step 1 – Inspect the stock: Allow the quantum dot stock vial to equilibrate to room temperature before opening. Gently vortex or sonicate (bath sonicator, 30–60 seconds) to ensure a homogeneous dispersion. Do not use probe sonication, as this may damage the ZnS shell.

Step 2 – Determine concentration: Measure absorbance at the first excitonic absorption peak using a UV-Vis spectrophotometer. Use the molar extinction coefficient provided in the product Certificate of Analysis (CoA) to calculate the molar concentration via Beer–Lambert law (A = ε·c·l). Flag: verify lot-specific extinction coefficient from CoA; do not assume a universal value.

Step 3 – Prepare working dilution: Dilute the stock in the appropriate solvent (e.g., toluene for hydrophobic dots; PBS or HEPES buffer for aqueous, surface-functionalised dots) to the desired working concentration. Typical working concentrations for imaging range from 1–100 nM, but optimise empirically for your application. Mix gently by pipetting; avoid vigorous vortexing of diluted solutions.

Step 4 – Filter if required: For cell imaging, pass the aqueous quantum dot solution through a 0.22 µm syringe filter to remove aggregates prior to use.

Fluorescence Imaging Setup and Acquisition

Excitation: CdSe/ZnS quantum dots can be excited across a broad wavelength range below their emission peak. Select an excitation source (laser line or bandpass-filtered lamp) at least 20–30 nm below the emission maximum to minimise spectral bleed-through. Common excitation wavelengths include 405 nm, 445 nm, or 488 nm laser lines depending on emission colour.

Emission filter selection: Choose a bandpass emission filter centred at the quantum dot emission peak (consult the lot-specific emission spectrum in the CoA). The narrow full-width at half-maximum (FWHM) of CdSe/ZnS dots (typically 20–40 nm) allows multiplexed imaging with minimal spectral overlap when multiple colours are used.

Acquisition settings: Begin with low excitation power to reduce photobleaching, then optimise exposure time and detector gain. Quantum dots exhibit blinking (fluorescence intermittency); for single-particle tracking, use short exposure times (≤100 ms) and high frame rates. For ensemble imaging, time-averaged acquisition reduces the visible effect of blinking.

Controls: Always include a no-quantum-dot negative control and, where applicable, a positive control with known labelling to validate signal specificity.

Storage, Stability and Troubleshooting

Storage: Store CdSe/ZnS quantum dot stock solutions at 2–8 °C in the dark. Keep vials tightly sealed to prevent solvent evaporation and oxidation. Do not freeze unless the specific product formulation is confirmed freeze-stable. Protect from prolonged UV or ambient light exposure, which can cause photooxidation of the surface ligands and reduction in quantum yield.

Common issues and solutions:

• Aggregation: If aggregation is observed (visible turbidity or red-shifted, broadened emission), briefly bath-sonicate the sample and re-filter through 0.22 µm. Review solvent compatibility and ionic strength of buffers.
• Reduced brightness: May indicate photooxidation, ligand loss, or degraded stock. Verify storage conditions and check lot expiry. Compare absorbance spectrum to reference; loss of excitonic features indicates degraded particles.
• High background fluorescence: Ensure all plasticware and buffers are free of fluorescent contaminants. Use amber tubes and minimise exposure to ambient light during sample preparation.
• Blinking artifacts in single-particle experiments: Use short acquisition windows and consider post-acquisition blinking analysis algorithms.

Frequently asked questions

What solvents are compatible with CdSe/ZnS quantum dots?

Solvent compatibility depends on the surface ligands. Hydrophobic, native-ligand quantum dots (e.g., TOPO- or oleylamine-capped) are typically dispersed in non-polar organic solvents such as toluene or hexane. Surface-functionalised or polymer-encapsulated variants can be dispersed in aqueous buffers (e.g., PBS, HEPES). Always consult the product datasheet or CoA for the specific formulation supplied.

How do I minimise photobleaching and blinking during imaging?

Use the minimum excitation power necessary to achieve adequate signal-to-noise ratio, and limit total light exposure by closing shutters between acquisitions. For single-particle studies, use short exposure times (≤100 ms per frame) and high-sensitivity detectors. Oxygen-depleting imaging buffers (e.g., containing glucose oxidase/catalase or PCA/PCD systems) can reduce photobleaching in aqueous systems. Note that blinking is an intrinsic quantum mechanical property of semiconductor nanocrystals and cannot be fully eliminated, only mitigated.

Can CdSe/ZnS quantum dots be used for live-cell imaging?

Yes, surface-functionalised CdSe/ZnS quantum dots (e.g., with PEG, carboxyl, or amine groups) that are dispersible in aqueous buffers can be applied in live-cell imaging. However, cytotoxicity must be carefully assessed because cadmium ions released from degraded quantum dots are toxic. Optimise concentration, incubation time, and surface chemistry for each cell type. Use the lowest effective concentration and validate cell viability with appropriate assays (e.g., MTT, live/dead staining) alongside imaging experiments.

How should I characterise the quantum dot emission before use?

Record a fluorescence emission spectrum using a fluorescence spectrophotometer with appropriate excitation (at least 20–30 nm below the expected emission peak). Compare the peak emission wavelength and FWHM to the lot-specific values in the CoA. A narrow, symmetric emission peak confirms particle quality. Significant peak broadening or red-shifted shoulders may indicate aggregation or a mixture of particle sizes.

References

1. Bruchez M Jr, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science. 1998;281(5385):2013-2016. doi:10.1126/science.281.5385.2013
2. Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science. 1998;281(5385):2016-2018. doi:10.1126/science.281.5385.2016
3. Resch-Genger U, Grabolle M, Cavaliere-Jaricot S, Nitschke R, Nann T. Quantum dots versus organic dyes as fluorescent labels. Nature Methods. 2008;5(9):763-775. doi:10.1038/nmeth.1248

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.